Renal cell carcinoma: standards and controversies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/article/10.1007/s00345-018-2490-5/fulltext.html
Reference16 articles.
1. Rossi SH, Klatte T, Usher-Smith J, Stewart GD (2018) Epidemiology and screening for renal cancer. World J Urol 36:1341–1353. https://doi.org/10.1007/s00345-018-2286-7
2. Rossi SH, Prezzi D, Kelly-Morland C, Goh V (2018) Imaging for the diagnosis and response assessment of renal tumours. World J Urol. https://doi.org/10.1007/s00345-018-2342-3
3. Scelo G, Muller DC, Riboli E et al (2018) KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case-control study. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-18-1496
4. Mitchell TJ, Rossi SH, Klatte T, Stewart GD (2018) Genomics and clinical correlates of renal cell carcinoma. World J Urol. https://doi.org/10.1007/s00345-018-2429-x
5. Warren AY, Harrison D (2018) WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol. https://doi.org/10.1007/s00345-018-2447-8
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma;Translational Oncology;2022-08
2. Identification and Verification of m7G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma;Frontiers in Immunology;2022-05-03
3. Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway;Bioengineered;2022-02-01
4. Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology;Bioscience Reports;2021-06
5. The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation;Cancer Cell International;2021-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3